Price$16.82-0.34 (-1.98%)
2026-03-042026-06-05
News · 26 weeks1-100%
2025-12-142026-06-07
Mix190d
- Earnings1(100%)
Latest news
2 items- PRProShares Announces ETF Share SplitsProShares, a premier provider of ETFs, announced today forward and reverse share splits on 17 of its ETFs. The splits will not change the total value of a shareholder's investment. Forward Split ProShares will implement a forward split for one ETF at the following split ratio: Ticker ProShares ETF Split Ratio NOBL ProShares S&P 500 Dividend Aristocrats ETF 2:1 This forward split will apply to shareholders of record as of market close on May 26, 2026, payable after market close on May 27, 2026. The forward split will be effective prior to market open on May 28, 2026, when the fund will begin trading at its post-split price. The ticker symbol and
- NEWSPsychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology IndexPsilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ:CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ:NBI), effective as of market open on Monday, Dec. 20. “We are proud to announce our addition to the esteemed Nasdaq Biotechnology Index,” George Goldsmith, CEO and founder of Compass Pathways said. “Our inclusion in this index enables us to reach new audiences as we continue to execute on our clinical development of our investigational COMP360 psilocybin therapy in hopes of addressing the most challenging issues in mental healthcare.” The NBI is designed to track the performance of a set of securities listed on the
BIS FAQ
7 questionsWhat does ProShares UltraShort Nasdaq Biotechnology do?
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.Where does BIS stock trade?
ProShares UltraShort Nasdaq Biotechnology (BIS) is listed on NASDAQ.What sector and industry is BIS in?
ProShares UltraShort Nasdaq Biotechnology operates in the n/a sector.When did ProShares UltraShort Nasdaq Biotechnology go public?
ProShares UltraShort Nasdaq Biotechnology (BIS) completed its IPO in n/a.Does BIS pay a dividend?
BIS's most recent ex-dividend date was 2026-03-25 with a cash dividend of $0.07 per share. No future ex-date is on file yet.What companies are similar to BIS?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare BIS side-by-side with any of them on Quantisnow.How can I track BIS on Quantisnow?
Quantisnow aggregates ProShares UltraShort Nasdaq Biotechnology's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BIS to receive live email and push alerts on every new disclosure.